Day: December 19, 2022

ARLINGTON, Va., Dec. 19, 2022 (GLOBE NEWSWIRE) — Edge Total Intelligence Inc. (“edgeTI”, “We”, “Our” or the “Company”), a leader in real-time digital operations solutions, announced it has awarded additional options to Sophic Capital for capital market strategy and investor relations services. Pursuant to the capital markets advisory agreement with Sophic Capital Inc. (“Sophic”) dated February 1, 2022 (the “Agreement”), as previously disclosed by press release dated February 07, 2022, the Company granted to Sophic an additional 89,935 options (the “Additional Options”) at an exercise price of $0.72 per option that were due prior to the board meeting. The Company previously granted to Sophic an initial 100,000 options under the Agreement (together with the Additional Options the “Options”)...

Dr. Uribe is the fourth national KOL to join the Aclarion team this year.  Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key opinion leader advocacy. Broomfield, CO, Dec. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that Juan Uribe M.D., Professor and Vice Chair, Department of Neurological Surgery, Chief Division of Spinal Disorders, and Volker K. H. Sonntag Chair of Spine Research at the Barrow Neurological Institute in Phoenix, Arizona will advise the company as a key opinion...

MIAMI, Dec. 19, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced that Lucy Lu, M.D., has been appointed to its Board of Directors. Dr. Lu is an accomplished executive with over 20 years of experience in a wide range of financial and drug development matters in the biotech and healthcare sectors as an investment banker, equity research analyst and executive at several biotech companies. Lindsay A. Rosenwald, M.D., Fortress’ Chairman and Chief Executive Officer, said, “We are delighted to welcome Lucy back to Fortress in a new capacity, as a member of our Board of Directors. Prior to her current role at Innovative Cellular...

Coalition to Leverage ThreatLabz expertise and Intelligence from Zscaler’s Cloud Security Platform to Strengthen Global Cyber Resiliency SAN JOSE, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) — Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced its membership in the Joint Cyber Defense Collaborative (JCDC), underscoring the company’s commitment to improving the nation’s cyber resiliency. JCDC, established by the Cybersecurity and Infrastructure Security Agency (CISA) in 2021, leads the development and implementation of joint cyber defense plans and operations through critical partnerships with the private sector, Federal government and state, local, tribal and territorial governments. Zscaler will work with JCDC to enhance the collective cybersecurity posture of the United States and strategic international partners. As...

EDISON, N.J., Dec. 19, 2022 (GLOBE NEWSWIRE) — Zerify Inc., (OTCQB: ZRFY), the 21-year-old cybersecurity company focused on secure video conferencing solutions, today announced that 21st Century Marketing Group has licensed Zerify Defender to protect confidential client data. According to Anthony Lombardi, President of 21st Century Marketing Group, a NY based benefits brokerage and consulting firm, “purchasing Zerify Defender was important for myself and my agency for two reasons: 1) to protect the data and privacy of my clients both during video conferencing as well as the 24/7 protection of my laptop and desktop when enrolling employees and members into a number of online benefit portals, 2) with the workforce today that is remote or hybrid, offering a unique proactive benefit solution to my clients and their employees will be...

SOUTH SAN FRANCISCO, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company innovating next-generation cell and gene therapies using its proprietary gene circuit platform, today announced that Tim Lu, MD, PhD, Co-founder and Chief Executive Officer, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 5:15 p.m. PT. A webcast of the presentation can be accessed under the “Events & Presentations” section of the Senti Bio website. About Senti BioOur mission is to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. To accomplish this, we are building a synthetic biology platform that may enable us to program next-generation cell...